Fluoride Varnish Randomized Clinical Trial

Sponsor
University of California, San Francisco (Other)
Overall Status
Completed
CT.gov ID
NCT00066963
Collaborator
(none)
376
1
3
50
7.5

Study Details

Study Description

Brief Summary

The purpose of this study is to compare the efficacy of fluoride varnish (FV) applied once or twice a year with counseling to counseling alone in preventing early childhood caries (ECC) (tooth decay in children under the age of five).

Condition or Disease Intervention/Treatment Phase
  • Device: Fluoride Varnish
Phase 3

Detailed Description

This project was a prospective, randomized clinical trial (RCT) among initially caries-free children from about six months old (when primary teeth erupt) up to age three at two public health facilities in San Francisco, one serving a primarily Latino and one a primarily Asian population. The RCT 1) Compared the efficacy of once or twice/year fluoride varnish (FV) application and counseling to counseling alone in preventing early childhood caries (ECC); 2) Assessed pre-intervention salivary markers (biologic and chemical), behavioral and demographic factors as predictors of ECC; 3) Compared the efficacy of these interventions between sites serving different ethnic populations with a high prevalence of ECC; and 4) Determined the salivary fluoride release profile following exposure to fluoride varnish.

Study Design

Study Type:
Interventional
Actual Enrollment :
376 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Comprehensive Oral Health Center for Discovery: New Strategies for Enhancing Tissue Integrity and Repair Early Childhood Caries: Prevention and Treatment Outcomes
Study Start Date :
Oct 1, 2002
Actual Primary Completion Date :
Nov 1, 2006
Actual Study Completion Date :
Dec 1, 2006

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Counseling Only

Counseling Only

Experimental: FV every 12mo for 24mo + Counsel

Preventive fluoride varnish every 12mo for 24mo plus Counseling

Device: Fluoride Varnish
0.1 mL (1 drop) applied on each of 2 arches
Other Names:
  • Duraphat® (Colgate Oral Pharmaceuticals)
  • Experimental: FV every 6mo for 24mo + Counseling

    Preventive fluoride varnish every 6mo for 24mo plus Counseling

    Device: Fluoride Varnish
    0.1 mL (1 drop) applied on each of 2 arches
    Other Names:
  • Duraphat® (Colgate Oral Pharmaceuticals)
  • Outcome Measures

    Primary Outcome Measures

    1. Number of Caries Incident Cases [two years]

      A trained, calibrated dentist blinded to treatment arm performed visual-tactile dental exams at 1 and 2 years post-baseline. Group-specific number of incident cases were reported as the number of individual participants with caries at a follow-up visit.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    6 Months to 36 Months
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes

    Inclusion

    • Children < 44 months old

    • Caries-free

    • 4 erupted maxillary incisors

    • Residing in fluoridated community (San Francisco)

    Exclusion

    • Cleft Palate

    • Developmental or learning disabilities

    • Children with transient residence (homeless, migrant, foster home)

    • Children with an another household member participating in the study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 UCSF School of Dentistry San Francisco California United States 94143-1361

    Sponsors and Collaborators

    • University of California, San Francisco

    Investigators

    • Principal Investigator: Jane A Weintraub, DDS, MPH, University of California, San Francisco (now Univ North Carolina)
    • Study Director: Francisco Ramos-Gomez, DDS, MPH, University of California, San Francisco (now Univ Calif Los Angeles)

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of California, San Francisco
    ClinicalTrials.gov Identifier:
    NCT00066963
    Other Study ID Numbers:
    • NIDCR-13058
    First Posted:
    Aug 8, 2003
    Last Update Posted:
    Mar 9, 2022
    Last Verified:
    Mar 1, 2022
    Keywords provided by University of California, San Francisco
    Additional relevant MeSH terms:

    Study Results

    Participant Flow

    Recruitment Details January 2001 - July 2002. Supplemental Nutrition Program for Women, Infants & Children (WICs); Womens resource center; medical clinics; pre-schools; dental clinics
    Pre-assignment Detail Cleft lip or palate, developmental or learning disabilities, older than 36 mos; younger than 6 mos,immuno-compromised, born outside SF Bay Area where water is non-fluoridated, lack parental consent; lack 4 maxillary incisors, have caries, other family member in study, transient parents, ineligible to use SF Health Dept service
    Arm/Group Title No Intervention: Counseling Only Experimental: FV Every 12mo for 24mo + Counsel Experimental: FV Every 6mo for 24mo + Counsel
    Arm/Group Description Counseling Only (0FV) Preventive fluoride varnish every 12mo for 24mo plus Counseling (2FV) Preventive fluoride varnish every 6mo for 24mo plus Counseling (4FV)
    Period Title: Overall Study
    STARTED 126 124 126
    COMPLETED 100 93 87
    NOT COMPLETED 26 31 39

    Baseline Characteristics

    Arm/Group Title No Intervention: Counseling Only Experimental: FV Every 12mo for 24mo + Counsel Experimental: FV Every 6mo for 24mo + Counsel Total
    Arm/Group Description Counseling Only (0FV) Preventive fluoride varnish every 12mo for 24mo plus Counseling (2FV) Preventive fluoride varnish every 6mo for 24mo plus Counseling (4FV) Total of all reporting groups
    Overall Participants 126 124 126 376
    Age (Count of Participants)
    <=18 years
    126
    100%
    124
    100%
    126
    100%
    376
    100%
    Between 18 and 65 years
    0
    0%
    0
    0%
    0
    0%
    0
    0%
    >=65 years
    0
    0%
    0
    0%
    0
    0%
    0
    0%
    Age (Year) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [Year]
    1.8
    (0.6)
    1.8
    (0.5)
    1.8
    (0.6)
    1.8
    (0.6)
    Sex: Female, Male (Count of Participants)
    Female
    68
    54%
    66
    53.2%
    64
    50.8%
    198
    52.7%
    Male
    58
    46%
    58
    46.8%
    62
    49.2%
    178
    47.3%
    Region of Enrollment (participants) [Number]
    United States
    126
    100%
    124
    100%
    126
    100%
    376
    100%

    Outcome Measures

    1. Primary Outcome
    Title Number of Caries Incident Cases
    Description A trained, calibrated dentist blinded to treatment arm performed visual-tactile dental exams at 1 and 2 years post-baseline. Group-specific number of incident cases were reported as the number of individual participants with caries at a follow-up visit.
    Time Frame two years

    Outcome Measure Data

    Analysis Population Description
    intention-to-treat with any follow-up information. multiple imputation for sensitivity analyses.
    Arm/Group Title Counseling Only FV 1x/Year + Counseling FV 2x/Year + Counseling
    Arm/Group Description caregiver counseling only (zero fluoride varnish) fluoride varnish (FV) (5% NaF, Duraphat®, Colgate) once per year for 2 years (every 12 months) plus caregiver counseling fluoride varnish (FV) (5% NaF, Duraphat®, Colgate) twice per year for 2 years (every 6 months)
    Measure Participants 100 93 87
    Number [participants]
    42
    33.3%
    23
    18.5%
    14
    11.1%
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Counseling Only, FV 1x/Year + Counseling, FV 2x/Year + Counseling
    Comments Planned sample size of 384 participants (128/study arm) (alpha = 0.05, power = 90%, 50% attrition, χ2 test) to detect caries incidence differences, based on caries incidence in the literature (20% to 50% over two years). 50% attrition in the sample size calculation was selected based on the literature (e.g. Weinstein et al., 1994 reported 53% attrition in six months.)
    Type of Statistical Test Superiority or Other (legacy)
    Comments
    Statistical Test of Hypothesis p-Value <0.001
    Comments
    Method Mantel Haenszel
    Comments 2 d.f.
    Method of Estimation Estimation Parameter Odds Ratio (OR)
    Estimated Value 3.8
    Confidence Interval (2-Sided) 95%
    1.9 to 7.6
    Parameter Dispersion Type:
    Value:
    Estimation Comments Counseling Only vs FV 2x/yr+Counseling

    Adverse Events

    Time Frame 3 years
    Adverse Event Reporting Description
    Arm/Group Title No Intervention: Counseling Only Experimental: FV Every 12mo for 24mo + Counsel Experimental: FV Every 6mo for 24mo + Counsel
    Arm/Group Description Counseling Only (0FV) Preventive fluoride varnish every 12mo for 24mo plus Counseling (2FV) Preventive fluoride varnish every 6mo for 24mo plus Counseling (4FV)
    All Cause Mortality
    No Intervention: Counseling Only Experimental: FV Every 12mo for 24mo + Counsel Experimental: FV Every 6mo for 24mo + Counsel
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total / (NaN) / (NaN) / (NaN)
    Serious Adverse Events
    No Intervention: Counseling Only Experimental: FV Every 12mo for 24mo + Counsel Experimental: FV Every 6mo for 24mo + Counsel
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/100 (0%) 0/93 (0%) 0/87 (0%)
    Other (Not Including Serious) Adverse Events
    No Intervention: Counseling Only Experimental: FV Every 12mo for 24mo + Counsel Experimental: FV Every 6mo for 24mo + Counsel
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/100 (0%) 0/93 (0%) 1/87 (1.1%)
    Skin and subcutaneous tissue disorders
    Ulcer on the cheek 0/100 (0%) 0 0/93 (0%) 0 1/87 (1.1%) 1

    Limitations/Caveats

    In a protocol deviation, children received placebo varnish for 10 months; this would be expected to bias the study toward the null of no difference among groups. The study did not address FV efficacy for children with extant or past caries.

    More Information

    Certain Agreements

    Principal Investigators are NOT employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Stuart Gansky
    Organization Professor, S/D- PREV/REST
    Phone 415-502-8094
    Email stuart.gansky@ucsf.edu
    Responsible Party:
    University of California, San Francisco
    ClinicalTrials.gov Identifier:
    NCT00066963
    Other Study ID Numbers:
    • NIDCR-13058
    First Posted:
    Aug 8, 2003
    Last Update Posted:
    Mar 9, 2022
    Last Verified:
    Mar 1, 2022